Thomson Reuters/Uni...
Health Care: Drugs
Illumina Inc. (ILMN: NASDAQ)
$72.00 2.35 | 3.37%
05/17/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 433.98M | 302.98M | 248.95M | 144.63M |
| Receivables | 214.98M | 173.89M | 165.60M | 157.75M |
| Inventories | 158.72M | 128.78M | 142.21M | 92.78M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 1.79B | 1.54B | 1.26B | 981.59M |
| Property, Plant & Equipment, Gross | 319.57M | 280.16M | 231.38M | 191.34M |
| Accumulated Depreciation & Depletion | 153.40M | 136.68M | 101.50M | 74.15M |
| Property, Plant & Equipment, Net | 166.17M | 143.48M | 129.87M | 117.19M |
| Intangibles | 130.20M | 106.48M | 70.02M | 43.79M |
| Other Non-Current Assets | 73.16M | 59.74M | 63.11M | 26.55M |
| Total Non-Current Assets | 779.04M | 651.22M | 580.72M | 448.35M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 2.57B | 2.20B | 1.84B | 1.43B |
| Accounts Payable | 65.73M | 49.81M | 66.74M | 52.78M |
| Short Term Debt | 36.97M | 0.00 | 311.61M | 290.20M |
| Other Current Liabilities | 0.00 | 19.34M | 0.00 | 0.00 |
| Total Current Liabilities | 304.57M | 237.58M | 534.52M | 441.24M |
| Long Term Debt | 805.41M | 807.37M | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 134.37M | 69.95M | 106.92M | 124.45M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 942.93M | 883.04M | 106.92M | 124.45M |
| Total Liabilities | 1.25B | 1.12B | 641.44M | 565.69M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 1.32B | 1.08B | 1.20B | 864.25M |
| Common Par | 1.70M | 1.67M | 1.52M | 1.44M |
| Additional Paid In Capital | 2.42B | 2.25B | 1.89B | 1.64B |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | 82.55M | -68.71M | -155.34M | -280.23M |
| Treasury Stock | -1.19B | -1.11B | -541.56M | -497.54M |
| Other Equity Adjustments | 2.12M | 2.12M | 1.76M | 2.83M |
| Total Capitalization | 2.12B | 1.88B | 1.20B | 864.25M |
| Total Equity | 1.32B | 1.08B | 1.20B | 864.25M |
| Total Liabilities & Stock Equity | 2.57B | 2.20B | 1.84B | 1.43B |
| Total Common Shares Outstanding | 123.94M | 122.04M | 126.61M | 119.48M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 46.23M | 44.66M | 24.90M | 24.07M |
| Basic Weighted Shares Outstanding | 123.00M | 123.40M | 123.58M | 123.15M |
| Diluted Weighted Shares Outstanding | 133.69M | 138.94M | 143.43M | 137.10M |
| Number of Employees | 2400 | 2200 | 2100 | 1781 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with ILMN
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- UserBender
- ContributorEarnings Short Squeeze Play...
- Contributor5 Stocks Hedge Funds Have B...
- ContributorMost-Searched Stocks for th...
- ContributorUptrending Short Squeeze Tr...
- Contributor15 Best Stocks at Top-Perfo...
- UserWatchlist
Latest ILMN Headlines from TheStreet
- Illumina Inc. (ILMN): Today's Featured Drugs Laggard 05.13.13 | 05:05 pm
- Illumina Rises On Unusually High Volume (ILMN) 05.10.13 | 03:05 pm
- Illumina Stock Hits New 52-Week High (ILMN) 05.08.13 | 12:05 pm
- Illumina Inc. (ILMN): Today's Featured Drugs Winner 05.06.13 | 05:05 pm
- Illumina Reaches New 52-Week High (ILMN) 04.30.13 | 12:04 pm
- Illumina Stock Hits New 52-Week High (ILMN) 04.23.13 | 10:04 am
- 5 Names Seeing Bullish Options Flow 04.18.13 | 12:04 pm
- Illumina Stock Hits New 52-Week High (ILMN) 04.10.13 | 04:04 pm
- Illumina Inc. (ILMN): Today's Featured Health Care Laggard 03.13.13 | 05:03 pm
- Illumina Inc. (ILMN): Today's Featured Drugs Winner 03.01.13 | 05:03 pm
Press Releases for ILMN
- Illumina Technology Enables Findings Of The Collaborative Oncological Gene-Environment Study (COGS) - Business Wire 03.27.13 | 12:03 pm
- Illumina Announces Favorable Outcome Of Its Patent Litigation Against Life Technologies, Inc. - Business Wire 03.21.13 | 04:03 pm
- Illumina Announces Outcome Of Its Patent Litigation Against Syntrix Biosystems, Inc. - Business Wire 03.14.13 | 09:03 pm
- Illumina Completes Acquisition Of Verinata Health - Business Wire 02.21.13 | 04:02 pm
- Illumina To Webcast Live Presentation At The Cowen And Company Annual Health Care Conference - Business Wire 02.20.13 | 06:02 am
- Illumina Reports Record Financial Results For Fourth Quarter And Fiscal Year 2012 - Business Wire 01.28.13 | 04:01 pm
- Illumina Announces Recipients Of Agricultural Greater Good Initiative Grants - Business Wire 01.15.13 | 06:01 pm
- Illumina To Announce Fourth Quarter And Fiscal Year 2012 Financial Results On Monday, January 28, 2013 - Business Wire 01.15.13 | 06:01 am
- Illumina Announces Sequencing Technology Innovations - Business Wire 01.08.13 | 12:01 pm
- Partners HealthCare And Illumina Announce Founding Members Of GeneInsight Network - Business Wire 01.07.13 | 02:01 pm
Partner Headlines for ILMN
- PerkinElmer, Inc. (PKI) Ex-Dividend Date Scheduled for April 17, 2013 - NASDAQ 04.16.13 | 01:04 pm
- Thermo Fisher Buying Life Tech At Premium Price - Investor's Business Daily 04.15.13 | 05:04 pm
- FEI Company (FEIC) Ex-Dividend Date Scheduled for April 08, 2013 - NASDAQ 04.05.13 | 01:04 pm
- Stocks Turn Mixed, Apple Rises; Stratasys, 3D Systems Tumbling - Investor's Business Daily 01.28.13 | 12:01 pm
- RIM, Green Mountain and Other Top Performing Nasdaq Stocks in November - Benzinga 12.01.12 | 01:12 pm
- Benzinga's M&A Chatter for Friday November 23, 2012 - Benzinga 11.24.12 | 10:11 am
- Benzinga's M&A Chatter for Wednesday November 21, 2012 - Benzinga 11.22.12 | 12:11 pm
- Parexel International Leads Medical Research Group - Investor's Business Daily 11.16.12 | 06:11 pm
- Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX) - Benzinga 11.12.12 | 01:11 pm
- Life Beats, FX Headwind Continues - Analyst Blog - Zacks 11.02.12 | 10:11 am
